(NASDAQ: CGNX) Cognex's forecast annual revenue growth rate of 8.41% is not forecast to beat the US Scientific & Technical Instruments industry's average forecast revenue growth rate of 15.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.9%.
Cognex's revenue in 2026 is $1,088,930,000.On average, 24 Wall Street analysts forecast CGNX's revenue for 2026 to be $196,653,671,298, with the lowest CGNX revenue forecast at $186,896,688,462, and the highest CGNX revenue forecast at $205,064,863,398. On average, 24 Wall Street analysts forecast CGNX's revenue for 2027 to be $215,158,293,918, with the lowest CGNX revenue forecast at $201,868,610,400, and the highest CGNX revenue forecast at $226,597,515,174.
In 2028, CGNX is forecast to generate $233,326,468,854 in revenue, with the lowest revenue forecast at $214,148,950,866 and the highest revenue forecast at $247,120,823,898.